|Day's Range||0.00 - 0.00|
|52 Week Range|
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Good news about this anti-clotting drug bodes well for the whole pipeline.
These stocks led the market lower. Find out why.
Cash from partners are paying the biotech's bills as its pipeline advances.